Brief: Protagonist Therapeutics Inc Cash Runway Extended Through Q4 2027
27/02/2024 22:09
Protagonist Therapeutics Inc PTGX.O :
* PROTAGONIST THERAPEUTICS INC: CASH RUNWAY EXTENDED THROUGH
Q4
2027
Source text for Eikon: ID:n0001104659-24-028208
Further company coverage: PTGX.O
Recent news on Protagonist Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI International
US FDA approves Takeda, Protagonist's drug for rare blood cancer (updated)
US FDA approves Takeda, Protagonist's drug for rare blood cancer
Silence Therapeutics jumps after mid-stage trial data for blood cancer drug
Protagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary